Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NDI Guidance Protects Public Health And Allows Innovation – FDA's Fabricant

This article was originally published in The Tan Sheet

Executive Summary

Present and former top FDA officials with oversight of dietary supplements defend the draft guidance on new dietary ingredient notifications, saying the document serves important public health priorities and will not be onerous to industry.
Advertisement

Related Content

Probiotics Industry Says FDA Regulatory Bar Is Set Too High
Probiotics Industry Says FDA Regulatory Bar Is Set Too High
New Dietary Ingredient Notification Draft Guidance Must Be Withdrawn – CRN and CHPA
Embria Studies FDA Expectations Before Successful EpiCor NDI
New Dietary Ingredient Notification Draft Guidance Must Be Withdrawn – CRN and CHPA
Embria Studies FDA Expectations Before Successful EpiCor NDI
NDI Guidance Sparks Questions Even From Firms Ready To Comply
NDI Guidance Sparks Questions Even From Firms Ready To Comply
Low NDI Notice Compliance Sets Stage For Enforcement – FDA’s Fabricant
FDA New Dietary Ingredient Meeting To Focus On Submission Shortfalls

Topics

Advertisement
UsernamePublicRestriction

Register

PS105168

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel